Quick summary: Sodium Chloride Injections: Solution bags may be leaking in affected lots. Date: 2023-07-20.
Public recall detail
Sodium Chloride Injections: Solution bags may be leaking in affected lots
2023-07-20
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Sodium Chloride Injections: Solution bags may be leaking in affected lots. Date: 2023-07-20.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandBaxter
ProductSodium Chloride Injections, USP
IssueHealth products - Packaging
Recall classType I
IdentificationRA-73977
Affected products
BrandBaxter
Product3% Sodium Chloride Injection, USP
DIN / NPN / authorizationDIN 00060232
Dosage formSolution
StrengthSODIUM CHLORIDE 3 G / 100 ML
LotW3C28C1, W3D04C1
BrandBaxter
Product0.9% Sodium Chloride Injection, USP
DIN / NPN / authorizationDIN 00060208
Dosage formSolution
StrengthSODIUM CHLORIDE 900 MG / 100 ML
LotW3A09B0, W3A10B0, W3A14B0, W3A16B0, W3A17B0, W3A18B0, W3A23B0, W3A26C2, W3A27C0, W3A28B0, W3B04B0, W3B14C0, W3B21B0, W3B22B0, W3B23B1, W3B25C0, W3B27B0, W3B28B0 W3C06B0, W3C07B0, W3C09B0, W3C10B0, W3C11B0, W3C13B0, W3C20B0, W3C24C2, W3C25C0, W3C29B0, W3D10B0, W3D10B0S, W3D17B0, W3D17B0S, W3A05C0, W3A06C0, W3A10C0, W3A13C0, W3A19C0, W3A25C0, W3A31C0, W3B08C0, W3B09C1X, W3B10C1X, W3B15C0, W3B16C0, W3B22C0, W3B23C0, W3B28C0, W3C09C2, W3C11C0, W3C16C0, W3C21C0, W3C24C0, W3C28C0 W3C28C0S W3D04C0, W3D05C0, W3D13C2 W3D14C0, W3C07C0SX, W3C07C0X, W3C22C0
Issue
Solution bags may be leaking in affected lots.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesBAXTER CORPORATION 7125 Mississauga Road, Mississauga Ontario Canada L5N 0C2
DistributionAlberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Ontario Prince Edward Island Quebec Saskatchewan Yukon
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-73977
Background{}
CompaniesBAXTER CORPORATION 7125 Mississauga Road, Mississauga Ontario Canada L5N 0C2
AudiencesGeneral public Healthcare Industry
Source updated2023-07-20
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.